Palo Alto Investors’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$336K	Hold	24,500	–	–	0.07%	43
2025 Q1	$271K	Hold	24,500	–	–	0.05%	40
2024 Q4	$261K	Hold	24,500	–	–	0.04%	39
2024 Q3	$311K	Hold	24,500	–	–	0.04%	44
2024 Q2	$411K	Hold	24,500	–	–	0.05%	39
2024 Q1	$368K	Hold	24,500	–	–	0.04%	38
2023 Q4	$368K	Hold	24,500	–	–	0.03%	34
2023 Q3	$343K	Hold	24,500	–	–	0.03%	29
2023 Q2	$254K	Hold	24,500	–	–	0.02%	30
2023 Q1	$226K	Hold	24,500	–	–	0.02%	30
2022 Q4	$217K	Hold	24,500	–	–	0.02%	28
2022 Q3	$204K	Hold	24,500	–	–	0.02%	32
2022 Q2	$201K	Hold	24,500	–	–	0.02%	31
2022 Q1	$213K	Hold	24,500	–	–	0.02%	35
2021 Q4	$233K	Hold	24,500	–	–	0.01%	37
2021 Q3	$412K	Hold	24,500	–	–	0.02%	37
2021 Q2	$374K	Hold	24,500	–	–	0.02%	40
2021 Q1	$477K	Hold	24,500	–	–	0.03%	39
2020 Q4	$441K	Hold	24,500	–	–	0.02%	37
2020 Q3	$473K	Hold	24,500	–	–	0.03%	39
2020 Q2	$640K	Hold	24,500	–	–	0.04%	36
2020 Q1	$437K	Buy	+24,500	New	+$437K	0.04%	33